The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase 2 study.
 
Juan Du
No Relationships to Disclose
 
Fan Tong
No Relationships to Disclose
 
Hui-zi Sha
No Relationships to Disclose
 
Yi Sun
No Relationships to Disclose
 
Yahui Zhu
No Relationships to Disclose
 
Liang Qi
No Relationships to Disclose
 
Xiaoqin Li
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Yan Yang
No Relationships to Disclose
 
Zeqing Li
No Relationships to Disclose
 
Caihua Xu
No Relationships to Disclose
 
Jiayao Ni
No Relationships to Disclose
 
Qing Gu
No Relationships to Disclose
 
Xing Zhang
Employment - Jiangsu Simcere Diagnostics
 
Chan Zhu
Employment - Jiangsu Simcere Diagnostics
 
Xiaoxuan Wang
Employment - Jiangsu Simcere Diagnostics
 
Baorui Liu
No Relationships to Disclose